pfizer glp 1 agonist discontinues oral GLP-1 receptor danuglipron Focus on Glucagon-like Peptide-1 Target:

and increased insulin early AUC and C-peptide total and early AUCs

22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

The answer is yes

This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.